logo

BH_NonClinical_Pharmacy_Car-T

One of 10,000+ tenders Taiyo tracks in United Kingdom.

Source: Find a Tender Service (UK)

Tender
Complete

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to ext

Status
Closed
Sector
Automotive
Location
United Kingdom
Updated
3 Nov 2026
Source
Find a Tender Service (UK)

ConstructChat

Ask ConstructChat about BH_NonClinical_Pharmacy_Car-T

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “BH NonClinical Pharmacy Car-T” is a tender record in Taiyo, linked to the Automotive sector. It is issued for works, goods, or services related to United Kingdom.

Participants

Not available for this record.

Status

Original status

complete

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.

Location

Country

United Kingdom (UK)

Source

Source

Find a Tender Service (UK)

URL

More Details

Record type

Tender

Sector

Automotive

Article published date

2026-09-21

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender